Lupin partners with Cost Plus Drugs, COPD Foundation
The collaboration seeks to expand availability of Tiotropium Bromide Inhalation Powder, 18 mcg/capsule, to COPD patients in the US…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
COPD
Lupin receives approval from TGA Australia for Tiotropium dry powder
The product will be manufactured at Lupin’s Pithampur facility in India
Lupin signs MoU with Maha Govt to combat cardiovascular diseases and COPD
Collaboration to enhance healthcare services, ensure timely diagnosis, and improve accessibility of healthcare services
Zydus gets USFDA approval for Roflumilast Tablets, 250 mcg
Roflumilast reduces inflammation in the lungs that leads to chronic obstructive pulmonary disease (COPD)
Cipla launches Spirofy, strengthens its lung leadership position by facilitating early diagnosis for…
Spirofy is India's first pneumotach-based portable wireless Spirometer for diagnosis of Chronic Obstructive Pulmonary Disorder…
Lupin gets UK marketing authorisation for Luforbec 100/6 µg pMDI
Luforbec 100/6 µg pMDI is indicated for regular treatment of asthma and for the symptomatic treatment of patients with severe COPD
Lupin launches generic version of Brovana in US
It is indicated for the long-term, twice-daily maintenance treatment of bronchoconstriction in patients with COPD
Zydus Cadila launches COPD drug in India
Zydus Cadila is launching Forglyn pMDI, pressurised Metered Dose Inhaler (pMDI) with a combination of Long Acting Muscarinic…
GSK gets US FDA approval for Trelegy Ellipta to treat asthma, COPD
Trelegy is the first single inhaler triple therapy approved for the maintenance treatment of both asthma and COPD
AstraZeneca eyes three-drug inhaler opportunity after trial results
AstraZeneca said that the ETHOS trial of triple-drug therapy c formerly known as PT010, helped patients suffering from chronic…